Andrea Tan
Stock Analyst at Goldman Sachs
(0)
# 4358
Out of 5,334 analysts
52
Total ratings
35.71%
Success rate
-12.22%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeut... | Maintains: Buy | 16 8 | 1.95 | 310.26% | 7 | May 12, 2025 | |
TARS Tarsus Pharmaceutica... | Maintains: Neutral | 46 51 | 44.33 | 15.05% | 4 | May 5, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 39 27 | 6.59 | 309.71% | 6 | Mar 25, 2025 | |
INSM Insmed | Maintains: Strong Buy | 74 102 | 67.69 | 50.69% | 9 | Jul 10, 2024 | |
SGMT Sagimet Biosciences | Maintains: Neutral | 23 6 | 3.29 | 82.37% | 5 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 31 | 13.97 | 121.9% | 1 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 3 2 | 0.4 | 400% | 3 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Sell | 2 | 4.14 | -51.69% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 17 | n/a | n/a | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | 139.24 | 14.91% | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 2.06 | 1065.05% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 10 4 | 1.07 | 273.83% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 178 375 | 301.35 | 24.44% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 13 | 4.32 | 200.93% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | n/a | n/a | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | 0.17 | 2252.94% | 2 | May 24, 2022 |